The ATMP-PIT Portfolio, an ATMP collaborative project initiated in Wallonia
As part of an initiative launched by the Walloon government in April 2023, BioWin – The Health Cluster of Wallonia and the SPW Economy, Employment, Research (SPW-EER) were invited to collaborate on the development of a large-scale project to strengthen the value chain of the biotech sector in Wallonia and stimulate regional economic redeployment.
This project, hereafter referred to as ATMP-PIT (ATMP-Partenariat d’Innovation Technologique), targets advanced therapy medicinal products (ATMPs) as an innovative therapeutic area with high economic and societal potential for the region. ATMP-PIT builds on an ambitious national action plan and an exhaustive national mapping of the different players involved in the field which was initiated by BioWin in 2022 (the “ATMP Hub” roadmap).
The BioWin competitiveness cluster gathered members of the Walloon ATMP ecosystem to assemble diverse stakeholders central to the ATMP-PIT project. This project will involve a close collaboration and connectivity (expertise, infrastructures, funding) within a partnership of 26 actors (21 companies, 1 accredited research centre, and several research units and hospitals affiliated to 4 universities from the Wallonia-Brussels Federation).
The ATMP-PIT project has been designed with the intention of consolidating the consortium of stakeholders active along the whole ATMP value chain within an innovative portfolio of collaborative work packages. The present portfolio is built on 12 work packages (evaluated by BioWin and the SPW-EER) subdivided into 3 pillars, each dedicated to one category of next generation therapy (gene therapy, cell therapy, and novel therapeutic approaches based on exosomes and bacteriophages).
Over the 3 years of the project, the BioWin competitiveness cluster will act as the general coordinator of the ATMP-PIT project.